Moreover, statin treatment may also be beneficial to COVID patients by reducing the risk of complications, such as thrombosis, by reducing the serum level of PAI-1, and pulmonary fibrosis, by attenuating TGF-β signalling. The gene discussed is TGFB1; the disease is pulmonary fibrosis.